Apeiron Biologics Company
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
Technology:
Atrificial Vectors and Immune Cells, CAR-T therapy
Industry:
Atrificial Vectors and Immune Cells, End-to-end Drug Development, Private
Headquarters:
Vienna, Wien, Austria
Founded Date:
2005-01-01
Employees Number:
11-50
Funding Status:
N/A
Investors Number:
2
Total Funding:
25000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-05-18
Last Funding Type:
Corporate Round
Register and Claim Ownership